Esketamine does of 56 and 84 mg with comprehensive standard-of-care rapidly improved depressive symptoms in adolescents at risk for suicide.

If phase 3 trials of MM120 (lysergide d-tartrate) for anxiety and depression are successful, could the LSD-based drug become ...

Active Path Mental Health is proud to announce its expanded Transcranial Magnetic Stimulation (TMS) services for adolescents , offering a safe, non-invasive, and FDA-cleared treatment option for teens ...

It is now approved for adults with treatment-resistant depression (TRD) who have cycled through multiple treatments without relief. Spravato (esketamine) has been touted as a potential blockbuster ...

“Treatment-resistant forms of major depression are common and have large ... and suicidal thoughts. Esketamine is also being reviewed by the EMA, which is looking to make a decision later ...

Stigma surrounding mental health remains one of the biggest barriers to seeking care, and for many individuals, that stigma ...

He completed a fellowship in Interventional Neuropsychiatry and Neuromodulation at Massachusetts General Hospital, bringing extensive expertise to the management of treatment-resistant mental health ...

Most veterans and their family members are concerned about proposed cuts at the U.S. Department of Veterans Affairs, ...

but have yet to gain mainstream support. Ketamine also has shown promise, especially with treatment-resistant depression ...

A new treatment option has become available in Australia for treatment-resistant depression — esketamine nasal spray (Spravato), now listed on the PBS. While it’s early days, and like any ...